Literature DB >> 19572264

Local complement activation in nasal polyposis.

Thibaut Van Zele1, Frauke Coppieters, Philippe Gevaert, Gabriele Holtappels, Paul Van Cauwenberge, Claus Bachert.   

Abstract

OBJECTIVES/HYPOTHESIS: The role of the complement system in nasal polyps (CRSwNP) has so far scarcely been studied. Because nasal polyps are characterized by bacterial colonization, and the complement system is an effective defense mechanism, it might be involved in the pathogenesis of CRSwNP. This study was designed to investigate the local and systemic activation of the complement system in CRSwNP versus control mucosa in relation to the local and systemic eosinophilic and neutrophilic inflammation and local plasma exudation.
METHODS: Concentrations of complement factors C3a desArg and C5a desArg, and of albumin, alpha2-macroglobulin, eosinophilic cationic protein, and myeloperoxidase were determined on nasal secretions and serum from 12 CRSwNP patients and 10 control patients. Tissue cryosections were stained for the membrane attack complex (C5b9)
RESULTS: We found a significantly higher concentration of C3a desArg and C5a desArg in nasal secretions from CRSwNP patients compared to controls, whereas the serum levels between the two groups did not differ significantly. Significant correlations were found between C5a desArg and eosinophil cationic protein in nasal secretions. Staining for the membrane attack complex revealed a deposition around blood vessels and the basal membrane exclusively in nasal polyp tissue.
CONCLUSIONS: These data support the hypothesis that, in addition to the adaptive immune responses, the complement system is involved in the pathogenesis of CRSwNP and may contribute to typical features such as edema and granulocytic inflammation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19572264     DOI: 10.1002/lary.20484

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  14 in total

1.  Classical complement pathway activation in the nasal tissue of patients with chronic rhinosinusitis.

Authors:  Griet A Van Roey; Christopher C Vanison; Jeffanie Wu; Julia H Huang; Lydia A Suh; Roderick G Carter; James E Norton; Stephanie Shintani-Smith; David B Conley; Kevin C Welch; Anju T Peters; Leslie C Grammer; Kathleen E Harris; Kathryn E Hulse; Atsushi Kato; Whitney W Stevens; Robert C Kern; Robert P Schleimer; Bruce K Tan
Journal:  J Allergy Clin Immunol       Date:  2016-12-12       Impact factor: 10.793

2.  Evidence for intranasal antinuclear autoantibodies in patients with chronic rhinosinusitis with nasal polyps.

Authors:  Bruce K Tan; Quan-Zhen Li; Lydia Suh; Atsushi Kato; David B Conley; Rakesh K Chandra; Jinchun Zhou; James Norton; Roderick Carter; Monique Hinchcliff; Kathleen Harris; Anju Peters; Leslie C Grammer; Robert C Kern; Chandra Mohan; Robert P Schleimer
Journal:  J Allergy Clin Immunol       Date:  2011-10-13       Impact factor: 10.793

Review 3.  Gene expression signatures: a new approach to understanding the pathophysiology of chronic rhinosinusitis.

Authors:  Chunwei Li; Li Shi; Yan Yan; Bruce R Gordon; William M Gordon; De-Yun Wang
Journal:  Curr Allergy Asthma Rep       Date:  2013-04       Impact factor: 4.806

4.  Endotypes and phenotypes of chronic rhinosinusitis: a PRACTALL document of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma & Immunology.

Authors:  Cezmi A Akdis; Claus Bachert; Cemal Cingi; Mark S Dykewicz; Peter W Hellings; Robert M Naclerio; Robert P Schleimer; Dennis Ledford
Journal:  J Allergy Clin Immunol       Date:  2013-04-12       Impact factor: 10.793

5.  IL-5Rα marks nasal polyp IgG4- and IgE-expressing cells in aspirin-exacerbated respiratory disease.

Authors:  Kathleen M Buchheit; Daniel F Dwyer; Jose Ordovas-Montanes; Howard R Katz; Erin Lewis; Marko Vukovic; Juying Lai; Lora G Bankova; Neil Bhattacharyya; Alex K Shalek; Nora A Barrett; Joshua A Boyce; Tanya M Laidlaw
Journal:  J Allergy Clin Immunol       Date:  2020-03-19       Impact factor: 10.793

6.  Outer membrane protein P5 is required for resistance of nontypeable Haemophilus influenzae to both the classical and alternative complement pathways.

Authors:  Charles V Rosadini; Sanjay Ram; Brian J Akerley
Journal:  Infect Immun       Date:  2013-11-25       Impact factor: 3.441

7.  Multidimensional endotypes of chronic rhinosinusitis and their association with treatment outcomes.

Authors:  B Liao; J-X Liu; Z-Y Li; Z Zhen; P-P Cao; Y Yao; X-B Long; H Wang; Y Wang; R Schleimer; Z Liu
Journal:  Allergy       Date:  2018-01-26       Impact factor: 13.146

Review 8.  Local immunoglobulin production in nasal tissues: A key to pathogenesis in chronic rhinosinusitis with nasal polyps and aspirin-exacerbated respiratory disease.

Authors:  Kathleen M Buchheit; Kathryn E Hulse
Journal:  Ann Allergy Asthma Immunol       Date:  2020-10-13       Impact factor: 6.347

9.  Activation-induced cytidine deaminase (AID)-associated multigene signature to assess impact of AID in etiology of diseases with inflammatory component.

Authors:  Diana Mechtcheriakova; Yury Sobanov; Gabriele Holtappels; Erika Bajna; Martin Svoboda; Markus Jaritz; Claus Bachert; Erika Jensen-Jarolim
Journal:  PLoS One       Date:  2011-10-03       Impact factor: 3.240

10.  Staphylococcus aureus and Chronic Airway Disease.

Authors:  Lara Derycke; Claudina Pérez-Novo; Koen Van Crombruggen; Marie-Noëlle Corriveau; Claus Bachert
Journal:  World Allergy Organ J       Date:  2010-08       Impact factor: 4.084

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.